Overview

MK0767 and Metformin Combination Study (0767-028)

Status:
Terminated
Trial end date:
2003-12-01
Target enrollment:
Participant gender:
Summary
A study to test the effects of MK0767 when added to Metformin in patients with inadequately controlled Type 2 Diabetes Mellitus. This is an early phase trial and some specific protocol information is in progress and not publicly available at this time. (Full information is available to trial participants).
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.